Americans pay 3–5x more for the same prescriptions that Canadians and Europeans pick up for a fraction of the cost. Rob Burgess wants to know why — and in Episode 1 of Bust Big Pharma, he's not letting the industry off the hook.

Bust Big Pharma is a project of Americans for Pharma Reform. Not anti-medicine. Not anti-innovation. Anti-exploitation.

This episode covers the full indictment: nearly 1,000 drug price hikes already in 2026, $6 billion in TV advertising last year, and a congressional hearing where pharma's own trade association claimed it didn't know enough about drug pricing to answer questions. (They lobby Congress on drug pricing for a living.) Rob also breaks down Trump's Most Favored Nation pricing push — what it actually means, why Big Pharma is fighting it behind closed doors, and how their own earnings calls expose the lie they keep telling about innovation.

What's covered:

• The congressional hearing that proved exactly why this podcast exists
• $266,000 per second in Super Bowl ads from an industry that claims tight margins
• Why the US and New Zealand are the only two countries on earth that allow direct-to-consumer drug advertising
• $38 million in Capitol Hill lobbying — and what it's buying
• MFN pricing in plain English
• The one word pharma used on their earnings calls that dismantles their entire argument

🔔 New episodes every week — subscribe so you don't miss one. 🌐 Get involved at BustBigPharma.com